KEGG   DRUG: Dornase alfaHelp
Entry
D03896                      Drug                                   

Name
Dornase alfa (USAN/INN);
Dornase alfa (genetical recombination) (JAN);
Pulmozyme (TN)
Product
Formula
C1321H1995N339O396S9
Exact mass
29231.3879
Mol weight
29249.5937
Remark
Therapeutic category: 2290
ATC code: R05CB13
Product: D03896<JP/US>
Efficacy
Mucolytic
  Disease
Cystic fibrosis [DS:H00218]
Comment
Recombinant human DNase
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 R RESPIRATORY SYSTEM
  R05 COUGH AND COLD PREPARATIONS
   R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS
    R05CB Mucolytics
     R05CB13 Dornase alfa (desoxyribonuclease)
      D03896  Dornase alfa (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
 Respiratory Tract/Pulmonary Agents
  Cystic Fibrosis Agents
   Cystic Fibrosis Agents, Other
    Dornase Alfa
     D03896  Dornase alfa (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  22  Respiratory organ agents
   229  Miscellaneous
    2290  Miscellaneous
     D03896  Dornase alfa (USAN/INN); Dornase alfa (genetical recombination) (JAN)
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D03896
BRITE hierarchy
Other DBs
CAS: 143831-71-4
PubChem: 17397980
DrugBank: DB00003

» Japanese version   » Back

DBGET integrated database retrieval system